Zornoff, Leonardo Antonio Mamede [UNESP]Paiva, Sergio Alberto Rupp de [UNESP]Assalin, Vanessa M. [UNESP]Pola, Patrícia M. S. [UNESP]Becker, Luís E. [UNESP]Okoshi, Marina Politi [UNESP]Matsubara, Luiz Shiguero [UNESP]Inoue, Roberto M. T. [UNESP]Spadaro, Joel [UNESP]2014-05-202014-05-202002-04-01Arquivos Brasileiros de Cardiologia. Sociedade Brasileira de Cardiologia - SBC, v. 78, n. 4, p. 401-405, 2002.0066-782Xhttp://hdl.handle.net/11449/11288OBJECTIVE: To evaluate clinical profiles, predictors of 30-day mortality, and the adherence to international recommendations for the treatment of myocardial infarction in an academic medical center hospital. METHODS: We retrospectively studied 172 patients with acute myocardial infarction, admitted in the intensive care unit from January 1992 to December 1997. RESULTS: Most patients were male (68%), white (97%), and over 60 years old (59%). The main risk factor for coronary atherosclerotic disease was systemic blood hypertension (63%). Among all the variables studied, reperfusion therapy, smoking, hypertension, cardiogenic shock, and age were the predictors of 30-day mortality. Most commonly used medications were: acetylsalicylic acid (71%), nitrates (61%), diuretics (51%), angiotensin-converting enzyme inhibitors (46%), thrombolytic therapy (39%), and beta-blockers (35%). CONCLUSION: The absence of reperfusion therapy, smoking status, hypertension, cardiogenic shock, and advanced age are predictors of 30-day mortality in patients with acute myocardial infarction. In addition, some medications that are undoubtedly beneficial have been under-used after acute myocardial infarction.401-405engmyocardial infarctionmortalitytreatmentArtigo10.1590/S0066-782X2002000400007S0066-782X2002000400007Acesso abertoS0066-782X2002000400007.pdf446313867199843263098351379987665016839015394547